Antisense oligonucleotide inhibition of cholesteryl ester transfer protein enhances RCT in hyperlipidemic, CETP transgenic, LDLr-/- mice
about
Advances in the Study of the Antiatherogenic Function and Novel Therapies for HDLCholesteryl ester transfer protein (CETP) deficiency and CETP inhibitors.Regulation of Hepatic Cholesteryl Ester Transfer Protein Expression and Reverse Cholesterol Transport by Inhibition of DNA Topoisomerase IICETP inhibitors downregulate hepatic LDL receptor and PCSK9 expression in vitro and in vivo through a SREBP2 dependent mechanism.A novel atheroprotective role of MF59-like adjuvant when co-administered with CETP vaccine in rabbit model of atherosclerosis.
P2860
Antisense oligonucleotide inhibition of cholesteryl ester transfer protein enhances RCT in hyperlipidemic, CETP transgenic, LDLr-/- mice
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antisense oligonucleotide inhi ...... CETP transgenic, LDLr-/- mice
@en
Antisense oligonucleotide inhi ...... CETP transgenic, LDLr-/- mice.
@nl
type
label
Antisense oligonucleotide inhi ...... CETP transgenic, LDLr-/- mice
@en
Antisense oligonucleotide inhi ...... CETP transgenic, LDLr-/- mice.
@nl
prefLabel
Antisense oligonucleotide inhi ...... CETP transgenic, LDLr-/- mice
@en
Antisense oligonucleotide inhi ...... CETP transgenic, LDLr-/- mice.
@nl
P2093
P2860
P356
P1476
Antisense oligonucleotide inhi ...... CETP transgenic, LDLr-/- mice
@en
P2093
Dan Norris
Mark J Graham
Richard G Lee
Rosanne M Crooke
Thomas A Bell
P2860
P304
P356
10.1194/JLR.M036509
P577
2013-06-25T00:00:00Z